157 related articles for article (PubMed ID: 8585744)
1. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
Shirasaka T; Chokekijchai S; Yamada A; Gosselin G; Imbach JL; Mitsuya H
Antimicrob Agents Chemother; 1995 Nov; 39(11):2555-9. PubMed ID: 8585744
[TBL] [Abstract][Full Text] [Related]
2. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
Gao WY; Agbaria R; Driscoll JS; Mitsuya H
J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
[TBL] [Abstract][Full Text] [Related]
3. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
[TBL] [Abstract][Full Text] [Related]
4. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
[TBL] [Abstract][Full Text] [Related]
5. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
Tsai CH; Doong SL; Johns DG; Driscoll JS; Cheng YC
Biochem Pharmacol; 1994 Oct; 48(7):1477-81. PubMed ID: 7945448
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells.
Gao WY; Mitsuya H; Driscoll JS; Johns DG
Biochem Pharmacol; 1995 Jul; 50(2):274-6. PubMed ID: 7632173
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV activity of novel phosphonate derivatives of AZT, d4T, and ddA.
Pokrovsky AG; Pronayeva TR; Fedyuk NV; Shirokova EA; Khandazhinskaya AL; Tarusova NB; Karpenko IL; Krayevsky AA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):767-9. PubMed ID: 11563112
[TBL] [Abstract][Full Text] [Related]
10. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Balzarini J
Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
[TBL] [Abstract][Full Text] [Related]
12. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB
Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782
[TBL] [Abstract][Full Text] [Related]
13. 3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analogues.
Van Aerschot A; Herdewijn P; Balzarini J; Pauwels R; De Clercq E
J Med Chem; 1989 Aug; 32(8):1743-9. PubMed ID: 2754700
[TBL] [Abstract][Full Text] [Related]
14. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
Mamber SW; Brookshire KW; Forenza S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
[TBL] [Abstract][Full Text] [Related]
15. In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI.
Chokekijchai S; Shirasaka T; Weinstein JN; Mitsuya H
Antiviral Res; 1995 Sep; 28(1):25-38. PubMed ID: 8585758
[TBL] [Abstract][Full Text] [Related]
16. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
18. Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus.
Bridges EG; Dutschman GE; Gullen EA; Cheng YC
Biochem Pharmacol; 1996 Mar; 51(6):731-6. PubMed ID: 8602867
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
Lake-Bakaar G; Mazzoccoli V; Dickman K; Lyubsky S
Dig Dis Sci; 2001 Sep; 46(9):1853-63. PubMed ID: 11575436
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral evaluation of some beta-L-2', 3'-dideoxy-5-chloropyrimidine nucleosides and pronucleotides.
Pierra C; Imbach JL; De Clercq E; Balzarini J; Van Aerschot A; Herdewijn P; Faraj A; Loi AG; Sommadossi JP; Gosselin G
Antiviral Res; 2000 Mar; 45(3):169-83. PubMed ID: 10771081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]